First Time Loading...

Advanced Medical Solutions Group PLC
LSE:AMS

Watchlist Manager
Advanced Medical Solutions Group PLC Logo
Advanced Medical Solutions Group PLC
LSE:AMS
Watchlist
Price: 208.955 GBX 0.7% Market Closed
Updated: May 14, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

289.2m
-0.8%
Assets
Growth Rates:
1 Year
+3%
3 Years
+21%
5 Years
+41%
7 Years
+99%
10 Years
+198%
45m
-8%
Liabilities
Growth Rates:
1 Year
+1%
3 Years
+24%
5 Years
+38%
7 Years
+131%
10 Years
+305%
244.2m
+0.6%
Equity
Growth Rates:
1 Year
+3%
3 Years
+21%
5 Years
+41%
7 Years
+95%
10 Years
+184%

Balance Sheet Decomposition
Advanced Medical Solutions Group PLC

289.2m
Assets
45m
Liabilities
289.2m
Assets
45m
Liabilities
Current Assets 122.3m
Cash & Short-Term Investments 60.2m
Receivables 26.1m
Other Current Assets 36m
Non-Current Assets 166.8m
PP&E 29.6m
Intangibles 136.3m
Other Non-Current Assets 949k
Current Liabilities 21.6m
Accounts Payable 19.3m
Other Current Liabilities 2.3m
Non-Current Liabilities 23.4m
Long-Term Debt 8m
Other Non-Current Liabilities 15.4m

Balance Sheet
Advanced Medical Solutions Group PLC

Rotate your device to view
Balance Sheet
Currency: GBP
Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022
Assets
Cash & Cash Equivalents
5
17
34
51
62
76
65
54
73
82
Cash
0
0
0
0
0
0
0
54
73
82
Cash Equivalents
5
17
34
51
62
76
65
0
0
0
Total Receivables
11
11
9
11
19
26
27
19
21
20
Accounts Receivables
10
11
9
10
19
25
26
18
18
18
Other Receivables
1
0
0
1
0
2
1
2
3
3
Inventory
8
8
9
11
11
15
18
21
19
28
Other Current Assets
1
1
1
1
2
2
2
3
2
1
Total Current Assets
26
38
54
75
95
119
112
97
115
132
PP&E Net
17
16
16
16
17
28
28
30
27
29
PP&E Gross
17
16
16
16
17
28
28
30
27
29
Accumulated Depreciation
10
10
12
14
16
20
23
26
28
31
Intangible Assets
14
13
12
14
15
15
33
42
41
48
Goodwill
39
37
35
40
42
42
54
69
66
71
Note Receivable
0
0
0
0
0
0
1
0
0
0
Other Long-Term Assets
2
1
0
0
0
1
0
0
0
1
Other Assets
39
37
35
40
42
42
54
69
66
71
Total Assets
97
N/A
105
+8%
117
+12%
145
+24%
169
+16%
205
+22%
227
+11%
239
+5%
250
+5%
281
+13%
Liabilities
Accounts Payable
2
2
3
3
3
4
7
7
5
6
Accrued Liabilities
3
3
4
5
6
6
3
4
6
7
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
1
1
1
1
1
Other Current Liabilities
3
3
3
6
4
8
5
2
5
8
Total Current Liabilities
8
8
10
15
13
19
17
15
17
23
Long-Term Debt
0
0
0
0
0
9
9
10
9
9
Deferred Income Tax
3
3
2
3
3
3
6
9
7
10
Other Liabilities
1
0
0
1
0
1
3
3
4
4
Total Liabilities
11
N/A
11
+3%
13
+12%
19
+51%
16
-16%
32
+100%
36
+10%
36
+2%
37
+1%
44
+21%
Equity
Common Stock
10
10
10
11
11
11
11
11
11
11
Retained Earnings
44
55
69
84
104
126
144
151
167
185
Additional Paid In Capital
32
33
33
34
35
35
36
36
37
37
Treasury Stock
0
0
0
0
0
0
0
0
0
0
Other Equity
0
5
9
3
3
1
0
4
2
3
Total Equity
86
N/A
93
+8%
104
+11%
126
+21%
152
+21%
173
+13%
191
+11%
202
+6%
213
+5%
237
+11%
Total Liabilities & Equity
97
N/A
105
+8%
117
+12%
145
+24%
169
+16%
205
+22%
227
+11%
239
+5%
250
+5%
281
+13%
Shares Outstanding
Common Shares Outstanding
207
208
209
210
213
214
215
215
216
217

See Also

Summary
AMS intrinsic value, competitors valuation, and company profile.
DCF Valuation
AMS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AMS stock valuation using valuation multiples.
Wall Street Estimates
AMS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AMS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.